Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
NPJ Breast Cancer|September 5, 2020
Breast cancer gene expression datasets do not reflect the disease at the population levelYanping Xie, Brittny C Davis Lynn, Nicholas Moir, et al.
Breast Cancer Research : BCR|June 16, 2019
On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancerRichard J Bownes, Arran K Turnbull, Carlos Martinez-Perez, et al.
Gynecologic Oncology|July 13, 2007
Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2007
Insulin-like growth factor binding proteins IGFBP3, IGFBP4, and IGFBP5 predict endocrine responsiveness in patients with ovarian cancerGraeme Walker, Kenneth MacLeod, Alistair R W Williams, et al.
Investigative Ophthalmology & Visual Science|May 2, 2009
Light responses in rods of vitamin A-deprived XenopusEduardo Solessio, Yumiko Umino, David A Cameron, et al.
The Journal of the Acoustical Society of America|December 31, 2024
Profile analysis in listeners with normal and elevated audiometric thresholds: Behavioral and modeling resultsDaniel R Guest, David A Cameron, Douglas M Schwarz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01Ruth E Langley, James Carmichael, Alison L Jones, et al.
Breast Cancer Research : BCR|April 11, 2013
Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?Alison F Munro, Annette Bartels, Eva Balslev, et al.
Breast Cancer Research and Treatment|September 18, 2022
Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009-2016: a cross-sectional studyAnushri Chitkara, Ines Mesa-Eguiagaray, Sarah H Wild, et al.
Endocrine-Related Cancer|December 13, 2006
Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer modelsBarbara Kuske, Catherine Naughton, Kate Moore, et al.
Pageof 17